BESREMI Trademark

Trademark Overview


On Friday, May 21, 2021, a trademark application was filed for BESREMI with the United States Patent and Trademark Office. The USPTO has given the BESREMI trademark a serial number of 90727699. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by PHARMAESSENTIA CORPORATION. The BESREMI trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; pre-filled syringes containing PEGylated interferons for medical purposes; anticancer pharmaceuticals; medicines for human purposes of treating cancers, polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs); western medicine, namely, ropeginterferon alfa-2b; active pharmaceutical ingredients for active pharmaceutical ingredients of ropeginterferon alfa-2b for treating cancers, PV and other MPNs; medicinal agent for human use, namely, pharmaceuticals for treating cancers or viral infections; biological preparations for medical purposes, namely, ropeginterferon alfa-2b; chemical preparations for medical purposes, namely, for cancers, PV and other MPNs; chemical-pharmaceutical preparations, namely, for treating cancers, PV and other MPNs; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes, namely, for treating cancers, PV and other MPNs; pharmaceutical preparations for treating cancers, PV and other MPNs
besremi

General Information


Serial Number90727699
Word MarkBESREMI
Filing DateFriday, May 21, 2021
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6830924
Registration DateTuesday, August 30, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements


Goods and ServicesImmunostimulants; pre-filled syringes containing PEGylated interferons for medical purposes; anticancer pharmaceuticals; medicines for human purposes of treating cancers, polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs); western medicine, namely, ropeginterferon alfa-2b; active pharmaceutical ingredients for active pharmaceutical ingredients of ropeginterferon alfa-2b for treating cancers, PV and other MPNs; medicinal agent for human use, namely, pharmaceuticals for treating cancers or viral infections; biological preparations for medical purposes, namely, ropeginterferon alfa-2b; chemical preparations for medical purposes, namely, for cancers, PV and other MPNs; chemical-pharmaceutical preparations, namely, for treating cancers, PV and other MPNs; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes, namely, for treating cancers, PV and other MPNs; pharmaceutical preparations for treating cancers, PV and other MPNs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePHARMAESSENTIA CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTAIPEI 11503
TW

Party NamePHARMAESSENTIA CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTAIPEI 11503
TW

Party NamePHARMAESSENTIA CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTAIPEI 11503
TW

Trademark Events


Event DateEvent Description
Tuesday, September 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, July 28, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, June 17, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 17, 2022TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, February 23, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 18, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, February 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Tuesday, May 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 25, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, May 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 25, 2021NEW APPLICATION ENTERED IN TRAM